Suchergebnisse - "drug discovery"

PubPharm (366)

91

Natural Compounds as Non-Nucleoside Inhibitors of Zika Virus Polymerase through Integration of In Silico and In Vitro Approaches

in: Pharmaceuticals | 2022

von Paulo Ricardo Pimenta da Silva Ramos | Melina Mottin | Caroline Sprengel Lima | +13

92

Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda

in: Pharmaceuticals | 2022

von Erik Karger | Marko Kureljusic

93

Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets

in: Pharmaceuticals | 2022

von Jesang Lee | Seung Bum Park

94

A Broad Spectrum Antiparasitic Activity of Organotin (IV) Derivatives and Its Untargeted Proteomic Profiling Using

in: Pathogens | 2022

von Obaid Hayat | Nazif Ullah | Muhammad Sirajuddin | +11

95

Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership

in: Diseases | 2022

von Sonja Bernhard | Marcel Kaiser | Christian Burri | +1

96

Deconstructing Markush: Improving the R&D Efficiency Using Library Selection in Early Drug Discovery

in: Pharmaceuticals | 2022

von Leticia Manen-Freixa | José I. Borrell | Jordi Teixidó | +1

97

In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, a Potential Novel Compound for Treating against

in: Pathogens | 2022

von Christian Bustamante | Andrés Felipe Díez-Mejía | Natalia Arbeláez | +5

98

Combination Therapy Assays with Doxorubicin and Cathepsin L Inhibitors against the Triple-Negative Breast Cancer Line MDA-MB-231

in: Medical Sciences Forum | 2022

von Talita Alvarenga Valdes | Isabela Marques | Andrei Leitao

99

Combinatorial technology revitalized by DNA‐encoding

in: MedComm | 2021

von Árpád Furka

100

Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease

in: Pharmaceuticals | 2021

von Massimiliano Runfola | Michele Perni | Xiaoting Yang | +16